Susquehanna International Group, LLP Galapagos Nv Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$24.78 - $32.48 $44,604 - $58,463	1,800 Added 10.34%	19,200 $475,000
Q1 2024 May 07, 2024	SELL	$32.2 - $42.44 $2.12 Million - $2.8 Million	-65,900 Reduced 79.11%	17,400 $560,000
Q4 2023 Feb 14, 2024	BUY	$31.87 - $40.71 $2.04 Million - $2.61 Million	64,100 Added 333.85%	83,300 $3.39 Million
Q3 2023 Nov 14, 2023	SELL	$34.17 - $42.98 $2.54 Million - $3.2 Million	-74,400 Reduced 79.49%	19,200 $663,000
Q2 2023 Aug 11, 2023	SELL	$37.4 - $44.52 $822,800 - $979,440	-22,000 Reduced 19.03%	93,600 $3.81 Million
Q1 2023 May 16, 2023	BUY	$36.5 - $48.0 $441,650 - $580,800	12,100 Added 11.69%	115,600 $4.47 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $1.69 Million - $2.1 Million	45,100 Added 77.23%	103,500 $4.59 Million
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $342,387 - $466,560	8,100 Added 16.1%	58,400 $2.49 Million

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.88B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.